Skip to main content

Table 1 Clinical characteristics of the healthy controls and patients in this study

From: Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema

Characteristics

Healthy (N = 26)

Transudates (N = 11)

Noninfectious exudates (N = 22)

UPPE (N = 40)

CPPE (N = 17)

Empyema (N = 21)

p valuea

Gender (M; F)

19; 7

10; 1

13; 9

34; 6

15; 2

15; 6

Age (years)

68.7; 67 (60–76)

74.7; 83 (59–88)

72.1; 80 (50–88)

71.6; 77 (58–86)

63.4; 58 (50–79)

68.6; 68 (59–82)

0.301

Pleural effusion

 Proteins (g/dl)

1.89; 1.86 (1.41–2.20)

3.79; 3.95 (2.91–4.50)

3.83; 3.64 (3.06–4.64)

4.52; 4.56 (4.06–5.08)

3.91; 4.38 (2.80–4.98)

<  0.001

 Glucose (mg/dl)

173.7; 156.0 (126.0–211.0)

154.2; 147.0 (102.5–178.3)

159.3; 141.0 (112.5–178.5)

47.6; 37.0 (9.0–70.5)

42.0; 21.0 (1.0–51.5)

<  0.001

 LDH (U/l)

80.3; 81.0 (53.0–95.0)

257.8; 209.0 (134.8–364.8)

360.2; 238.5 (142.8–654.5)

1217.0; 1112.0 (808.5–1546)

7213.0; 2738.0 (956.5–6590)

<  0.001

 pH

7.465; 7.451 (7.427–7.503)

7.435; 7.426 (7.364–7.480)

7.429; 7.404 (7.335–7.507)

7.192; 7.165 (7.131–7.277)

6.959; 6.957 (6.790–7.204)

<  0.001

  1. Data are presented as the mean; median (25–75 percentile)
  2. aThe p value of the Kruskal-Wallis test presents the difference between these groups